10 Apps To Help Manage Your ADHD Medication Pregnancy
ADHD Medication During Pregnancy and Breastfeeding
Women with ADHD must make a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breastfeeding. There isn't much information on how long-term exposure to these drugs may affect the fetus.
A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus don't develop neurological disorders like hearing or vision impairment seizures, febrile seizures or IQ impairment. The authors acknowledge that more high quality studies are needed.
Risk/Benefit Analysis
Women who are pregnant and taking ADHD medications must weigh the advantages of taking them against potential risks to the foetus. Physicians do not have the data needed to give clear guidelines, but they can provide information about the risks and benefits to help pregnant women make informed choices.
A study published in Molecular Psychiatry found that women who took ADHD medications during their early pregnancy did not face a significantly increased risk of fetal heart malformations or major birth defects that are structural. Researchers conducted a large sample-based case control study to examine the prevalence of major structural defects in infants born to mothers who were taking stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts looked over the cases to make sure that the classification was correct and to eliminate any bias.
However, the researchers' study had its limitations. The researchers were unable, in the first place to distinguish the effects of the medication from the disorder. This makes it difficult for researchers to determine if the few associations observed between the groups exposed were due to medication use, or if they were caused by the presence of comorbidities. Researchers also did not look at long-term outcomes for offspring.
The study showed that infants whose mother had taken ADHD medication during pregnancy had a slightly higher chance of being admitted to the neonatal care unit (NICU) in comparison to those whose mothers did not take any medication during pregnancy or stopped taking their medication before or during pregnancy. This was due to central nervous system disorders, and the increased risk for admission did not appear to be influenced by the stimulant medication was used during pregnancy.
Women who took stimulant ADHD medications during pregnancy also had a higher likelihood of having to have caesarean sections or one whose baby scored low on the Apgar scale (less than 7). These increases appeared to be independent of the type of medication used during pregnancy.
Researchers suggest that the small risks posed by the use of ADHD medications in early pregnancies can be offset by greater benefits to both baby and mother of continued treatment for the woman’s disorder. Physicians should talk to their patients about this issue and as much as possible, assist them develop coping skills that can lessen the impact of her disorder in her daily life and relationships.
Medication Interactions
As more women than ever are being diagnosed with ADHD and being treated with medication, the issue of whether to keep or end treatment during pregnancy is a question that doctors are having to face. These decisions are often made without clear and authoritative evidence. Instead, physicians must weigh their own knowledge in conjunction with the experiences of other physicians and the research on the subject.
The issue of potential risks to the infant can be difficult to determine. The research on this issue is based on observation rather than controlled studies, and a lot of the results are conflicting. Most studies restrict their analysis to live-births, which could underestimate the severity of teratogenic effects leading to terminations or abortions of pregnancy. The study that is discussed in the journal club addresses these shortcomings, by examining both information on deceased and live births.
Conclusion Some studies have shown a positive correlation between ADHD medications and certain birth defects however, other studies haven't shown such a relationship. Most studies show a neutral, or even slightly negative, effect. In all cases, a careful study of the benefits and risks should be conducted.
For women suffering from ADHD who suffer from ADHD, the decision to stop taking medication is difficult if not impossible. In a recent article published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of loneliness. Furthermore, a loss of medication may affect the ability to perform jobs and drive safely which are essential aspects of a normal life for many people suffering from ADHD.
She recommends that women who are unsure about whether or not to stop taking medication because of their pregnancy, consider educating family members, friends and colleagues about the condition, its impact on daily functioning, and on the advantages of continuing the current treatment plan. It can also make the woman feel more comfortable as she struggles with her decision. Some medications can pass through the placenta. If a woman decides not to take her ADHD medication while breastfeeding, it is crucial to be aware that the drug could be transferred to the baby.
Birth Defects and Risk of
As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows as do concerns about what impact the drugs could have on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this subject. Utilizing two huge data sets researchers were able look at more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. Although the risk overall is low, the researchers did find that first-trimester exposure to ADHD medications was associated with a slightly higher rate of specific heart defects, such as ventriculoseptal defect (VSD).
The researchers of the study did not find any association between early use of medication and other congenital anomalies, such as facial deformities or club feet. The results are consistent with previous studies showing the presence of a small, but significant increase in the risk of cardiac malformations among women who began taking ADHD medications prior to the time of pregnancy. The risk increased in the latter half of pregnancy when many women decided to stop taking their medication.
Women who used ADHD medication in the first trimester of pregnancy were also more likely to experience caesarean section, low Apgar score following delivery, and a baby who required help breathing at birth. The researchers of the study were not able to eliminate bias due to selection because they limited the study to women without other medical conditions that might have contributed to the findings.
Researchers hope that their study will help doctors when they encounter pregnant women. They suggest that although a discussion of the benefits and risks is important however, the decision to stop or continue medication should be based on the woman's needs and the severity of her ADHD symptoms.
The authors caution that, while stopping the medication is an option to think about, it isn't recommended due to the high rate depression and mental health issues in women who are expecting or recently gave birth. Further, the research suggests that women who decide to stop their medications are more likely to experience a difficult time adapting to life without them after the baby's arrival.
Nursing
It can be a stressful experience to become a mother. Women who suffer from ADHD who have to deal with their symptoms while attending physician appointments as well as making preparations for the arrival of their child and adjusting to new household routines may face a lot of challenges. Therefore, many women choose to continue taking their ADHD medications throughout pregnancy.
The majority of stimulant drugs pass through breast milk in very small amounts, so the risk for nursing infant is very low. However, the amount of exposure to medication by the newborn may differ based on the dosage, frequency it is administered and the time of the day it is administered. In addition, different medications are introduced into the baby's system through the gastrointestinal tract or breast milk. The impact of these medications on a newborn's health is not completely comprehended.
Some doctors may decide to stop stimulant medication during a woman's pregnancy due to the absence of research. It's a difficult choice for the mother, who must weigh the benefits of continuing her medication against the risk to the fetus. As long as more information is available, GPs may ask pregnant patients whether they have any history of ADHD or if they are planning to take medication during the perinatal stage.
A increasing number of studies have shown that most women can safely continue to take their ADHD medication during pregnancy and breastfeeding. In response, a growing number of patients are choosing to do so. They have discovered through consultation with their physicians, that the benefits of continuing their current medication outweigh any potential risks.
browse around this website with ADHD who are planning to nurse should seek the advice of a specialist psychiatrist before becoming pregnant. They should discuss their medication with their physician and discuss the advantages and disadvantages of continued treatment, including non-pharmacological management strategies. Psychoeducation is also required to help pregnant women suffering from ADHD be aware of the symptoms and the underlying disorder. They should also be educated about treatment options and build the coping mechanisms. This should be a multidisciplinary process together with obstetricians, GPs, and psychiatrists. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and the child, monitoring of signs of deterioration and, if necessary adjustments to the medication regimen.
